The VAF of this TP53 mutation increased from 26.7% in GBM to 50.8% in SGS (Figure 3D), indicating that the cellular prevalence of TP53 mutation increased from being present in approximately half of the tumor cells to virtually all of the tumor cells. The gene discussed is TP53; the disease is neoplasm.